The Gross Law Firm issues the following notice to shareholders of XPEL, Inc. (NASDAQ: XPEL). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of XPEL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: XPEL, Inc. […]

The Gross Law Firm issues the following notice to shareholders ofArbor Realty Trust, Inc. (NYSE: ABR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of ABR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: ABR

The Gross Law Firm issues the following notice to shareholders of Verve Therapeutics, Inc. (NASDAQ: VERV). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of VERV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Verve

The Gross Law Firm issues the following notice to shareholders ofEndava plc (NYSE: DAVA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of DAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Endava Loss Submission

The Gross Law Firm issues the following notice to shareholders ofModerna, Inc. (NASDAQ: MRNA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MRNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Moderna Loss Submission

The Gross Law Firm issues the following notice to shareholders of GitLab Inc. (NASDAQ: GTLB). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of GTLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: GitLab Loss

The Gross Law Firm issues the following notice to shareholders ofMacroGenics, Inc. (NASDAQ: MGNX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MGNX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: MacroGenics, Inc. Loss

The Gross Law Firm issues the following notice to shareholders ofVicor Corporation (NASDAQ: VICR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of VICR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Vicor Corporation Loss

The Gross Law Firm issues the following notice to shareholders ofSage Therapeutics, Inc. (NASDAQ: SAGE). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SAGE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Sage Therapeutics

The Gross Law Firm issues the following notice to shareholders ofDexCom, Inc. (NASDAQ: DXCM). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: DexCom, Inc. Loss